- Home
- » Tags
- » NMDA receptor antagonist
Top View
- The Competitive NMDA Receptor Antagonist CPP Disrupts Cocaine-Induced Conditioned Place Preference, but Spares Behavioral Sensitization
- Long-Term Ketamine Abuse and Apoptosis in Cynomologus Monkeys and Mice
- Special M: the Evolution of the Recreational Use of Ketamine and Methoxetamine
- United States Patent (19) 11 Patent Number: 5,925,634 Olney (45) Date of Patent: *Jul
- Journal of Psychopharmacology
- Minocycline Attenuates Hyperlocomotion and Prepulse Inhibition Deficits in Mice After Administration of the NMDA Receptor Antagonist Dizocilpine
- Autism, Pain, and the NMDA Receptor
- Slow Mg Unblock and Inherent Voltage Dependence of NMDA Receptors By
- Testing the NMDA, Long-Term Potentiation, and Cholinergic Hypotheses of Spatial Learning
- NMDA Antagonists; Both D- and L- Enantiomers of AP5 Infused
- BJP British Journal Of
- 1 Nitrous Oxide
- Activation of Glutamate Neurotransmission in the Prefrontal Cortex Sustains the Motoric and Dopaminergic Effects of Phencyclidine
- N-Methyl-D-Aspartate Receptor Antagonist D-Methadone Produces Rapid, Mtorc1-Dependent Antidepressant Effects
- Mechanisms of Nmda Receptor Inhibition by Memantine and Ketamine
- Effects of Nitrous Oxide on Dopamine Release in the Rat Nucleus Accumbens and Expectation of Reward
- The Ketamine Antidepressant Story: New Insights
- Opioid System Is Necessary but Not Sufficient for Antidepressive Actions of Ketamine in Rodents
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Dise
- Acute & Subchronic Nmda Receptor Blockade Alters
- Methoxetamine, a Ketamine Derivative, Produced Conditioned Place Preference and Was Self-Administered by Rats: Evidence of Its Abuse Potential
- The Effects of a 5-HT5A Receptor Antagonist in a Ketamine-Based Rat Model of Cognitive Dysfunction and the Negative Symptoms of Schizophrenia
- Neuronal and Immunological Basis of Action of Antidepressants in Chronic
- Spectral Signatures of Serotonergic Psychedelics and Glutamatergic Dissociatives
- Critical Review of KETAMINE
- Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS)
- Excessive Cerebrocortical Release of Acetylcholine Induced by NMDA
- Developmental Neurotoxicity of Ketamine in Pediatric Clinical Use
- A Novel NMDA Receptor Antagonist Protects Against Cognitive Decline Presented by Senescent Mice
- Dissociable Antidepressant-Like and Abuse-Related Effects of the Noncompetitive NMDA Receptor Antagonists Ketamine and MK-801 in Rats
- Hallucinogens
- Therapeutics of Schizophrenia (PDF)
- Increased Renal NMDA Receptor Subunit Expression in Akita Mice and Reduced Nephropathy Following Sustained Treatment with Memantine Or MK-801
- The Glycine/NMDA Receptor Antagonist, R-(+)-HA-966
- Direct Inhibition of the N-Methyl-D-Aspartate Receptor
- Methoxetamine a Foe Or Friend?
- Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization
- Relationship of Resting Brain Hyperconnectivity and Schizophrenia-Like Symptoms Produced by the NMDA Receptor Antagonist Ketamine in Humans
- Dextromethorphan: a Review of N-Methyl-D-Aspartate Receptor Antagonist in the Management of Pain
- Nitrous Oxide for Treatment-Resistant Major Depression a Proof-Of
- The M1/M4 Agonist Xanomeline Modulates Functional Connectivity and NMDAR Antagonist‐Induced Changes in the Mouse Brain
- Effect of Nitrous Oxide As a Treatment for Subjective
- Failures and Successes of NMDA Receptor Antagonists
- Ephenidine: a New Psychoactive Agent with Ketamine-Like NMDA Receptor Antagonist Properties
- Changes in Global Brain Connectivity in LSD-Induced Altered States of Consciousness Are Attributable to the 5-HT2A Receptor
- Ibogaine Scientific Literature Overview
- Quantitative Analysis of Tetrapentylammonium-Induced Blockade of Open N-Methyl-D-Aspartate Channels
- Aspartate Receptor Antagonists on Opiate Tolerance and Physical Dependence Keith A
- Federal Register/Vol. 86, No. 31/Thursday, February 18, 2021
- (12) Patent Application Publication (10) Pub. No.: US 2011/0054038A1 Glozman (43) Pub
- Changes in Global and Thalamic Brain Connectivity in LSD-Induced Altered
- The Role of NMDA Receptor Antagonist Drugs in the Acute Care Setting Debra Drew MS, ACNS-BC, RN-BC Christine Peltier BSN, RN-BC
- The Role of NMDA Receptor Antagonists in Nicotine Tolerance, Sensitization, and Physical Dependence: a Preclinical Review
- Clinically Available NMDA Receptor Antagonist Dextromethorphan Attenuates Acute Morphine Withdrawal in the Neonatal Rat
- Mechanisms Underlying Differential Effectiveness of Memantine and Ketamine in Rapid Antidepressant Responses
- Pharmacology of Dextromethorphan: Relevance to Dextromethorphan/Quinidine (Nuedexta®) Clinical Use
- FF #240 Levorphanol. 3Rd Ed
- Ketamine Update Review Report